Contact details
Anja Strangfeld
Main
Eva Voll
Alternate
Publications
Data source publications
- Baganz L, Listing J, Kekow J, Eisterhues C, Wassenberg S, Zink A, Strangfeld A. Different risk profiles of biologic agents for new-onset psoriasis in patients with rheumatoid arthritis. InSeminars in Arthritis and Rheumatism 2020 Feb 1 (Vol. 50, No. 1, pp. 36-41). WB Saunders.
- Schäfer M, Meißner Y, Kekow J, Berger S, Remstedt S, Manger B, Listing J, Strangfeld A, Zink A. Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis. Rheumatology. 2020 Aug 1;59(8):1916-26.
- Redeker I, Albrecht K, Kekow J, Burmester GR, Braun J, Schäfer M, Zink A, Strangfeld A. Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register. Annals of the Rheumatic Diseases. 2022 Jan 1;81(1):41-7.
- Schäfer M, Albrecht K, Kekow J, Rockwitz K, Liebhaber A, Zink A, Strangfeld A. Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT. RMD open. 2020 Oct 1;6(3):e001290.
- Meissner Y, Schaefer M, Schneider M, Wilden E, Zinke S, Zink A, Strangfeld A. Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT register. RMD open. 2020;6(3).